Vanguard Group
CADL icon

Vanguard Group’s Candel Therapeutics CADL Stock Holding History

Vanguard Group’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$13M Buy
2,305,060
+297,948
+15% +$1.6M ﹤0.01% 2826
2025
Q3 		$10.2M Buy
2,007,112
+219,563
+12% +$1.27M ﹤0.01% 2967
2025
Q2 		$9.04M Buy
1,787,549
+51,445
+3% +$265K ﹤0.01% 2956
2025
Q1 		$9.81M Buy
1,736,104
+396,954
+30% +$3.24M ﹤0.01% 2854
2024
Q4 		$11.6M Buy
1,339,150
+392,885
+42% +$2.32M ﹤0.01% 2871
2024
Q3 		$6.56M Buy
946,265
+127,715
+16% +$793K ﹤0.01% 3155
2024
Q2 		$5.08M Buy
818,550
+277,255
+51% +$2.08M ﹤0.01% 3261
2024
Q1 		$855K Buy
541,295
+115,546
+27% +$172K ﹤0.01% 3862
2023
Q4 		$626K Buy
425,749
+21,680
+5% +$21.1K ﹤0.01% 3968
2023
Q3 		$372K Sell
404,069
-1,686
-0.4% -$1.95K ﹤0.01% 4139
2023
Q2 		$511K Hold
405,755
– – ﹤0.01% 4115
2023
Q1 		$548K Hold
405,755
– – ﹤0.01% 4102
2022
Q4 		$726K Buy
405,755
+294
+0.1% +$582 ﹤0.01% 4004
2022
Q3 		$1.27M Hold
405,461
– – ﹤0.01% 3924
2022
Q2 		$1.31M Sell
405,461
-1,695
-0.4% -$6.79K ﹤0.01% 3995
2022
Q1 		$2.07M Sell
407,156
-8,197
-2% -$40.7K ﹤0.01% 3942
2021
Q4 		$3.25M Buy
415,353
+201,773
+94% +$1.96M ﹤0.01% 3840
2021
Q3 		$2.31M Buy
+213,580
New +$1.77M ﹤0.01% 4017

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HFF
Halter Ferguson Financial Carmel, Indiana $456M AUM 49.85% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group's CADL Position: Q4 2025 in Review

Vanguard Group increased its Candel Therapeutics (CADL) stake by 15% in Q4 2025, buying an estimated $1.6M and bringing the position to 2,305,060 shares worth $13M. The position accounts for ﹤0.01% of the portfolio, ranked #2826.

Vanguard Group first reported a position in CADL in Q3 2021 and has held it in 18 quarters since. 84 funds tracked by Wall St. Rank hold CADL as of Q4 2025.

  • Vanguard Group held 2,305,060 shares of Candel Therapeutics worth $13M as of Q4 2025.
  • Vanguard Group bought 297,948 Candel Therapeutics shares in Q4 2025, an estimated $1.6M.
  • Candel Therapeutics made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2826 holding.
  • Vanguard Group first reported a position in Candel Therapeutics in Q3 2021 and has held it in 18 quarters since.
  • 84 funds tracked by Wall St. Rank held Candel Therapeutics as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.